Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 19.0%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 154,200 shares, a decline of 19.0% from the November 15th total of 190,400 shares. Based on an average daily volume of 35,200 shares, the short-interest ratio is currently 4.4 days.

CNBX Pharmaceuticals Stock Performance

Shares of CNBX remained flat at $0.01 during trading hours on Friday. The stock had a trading volume of 90 shares, compared to its average volume of 181,553. CNBX Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.02. The firm’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.